Genesystem Co., Ltd. (KOSDAQ:363250)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Diagnostic Equipment Manufacturing Division	897.03M	3.65B
Diagnostic Equipment Manufacturing Division Growth	-75.44%	-
Total	897.03M	3.65B
Total Growth	-75.44%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
South Korea	245.12M	693.00M
South Korea Growth	-64.63%	-
Asia	466.77M	1.68B
Asia Growth	-72.26%	-
Europe	184.04M	1.23B
Europe Growth	-85.03%	-
North America	1.11M	975.00K
North America Growth	13.33%	-
Africa	-	47.46M
Total	897.03M	3.65B
Total Growth	-75.44%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error